David Flint, PhD
Department of Radiation Physics, Division of Radiation Oncology
Present Title & Affiliation
Primary Appointment
Assistant Professor, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dual/Joint/Adjunct Appointment
Associate Member, The University of Texas, Houston, Texas
Assistant Professor, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2021 | MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, US, Biomedical Sciences with Specialization in Medical Physics, PhD |
| 2013 | Carleton University, Ottawa, ON, CA, Physics and Chemistry (minor in Mathematics), B.Sc. Combined Honours |
Postgraduate Training
| 2022-2024 | Resident, Therapeutic Medical Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2021-2022 | Advanced Fellow in Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas |
Licenses & Certifications
| 2025 | Texas Medical Board |
| 2025 | Diplomate of the American Board of Radiology |
| 2024 | Texas Medical Board |
| 2023 | Texas Medical Board |
Experience & Service
Other Professional Positions
Course Director, GS02-1063: Fundamental anatomy, physiology, and biology for medical physicists, The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, 2025 - Present
Intramural Institutional Committee Activities
Member, PhD committee for Diya Choudhary, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, SBRT folder / 2nd Check Document in Brocade, The University of Texas MD Anderson Cancer Center, 2024 - Present
GI Physics Lead, Implementation of Rectal Brachytherapy, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Nomenclature Committee, The University of Texas MD Anderson Cancer Center, 2024 - 2025
GI Physics Lead, Implementation of SBPT for Liver, The University of Texas MD Anderson Cancer Center, 2024 - Present
Extramural Institutional Committee Activities
Member, 2026 Annual Meeting Organizing Committee, Radiation Research Society, 2025 - 2026
Honors & Awards
| 2022 | Aaron Blanchard Award, MD Anderson Cancer Center |
| 2021 | Advanced Fellowship in Radiation Physics, MD Anderson Cancer Center |
| 2020 | Farrington Daniels Award, American Association of Physicists in Medicine |
| 2019 | Best in Physics (Therapy), American Association of Physicists in Medicine |
| 2017 | SIT Travel Award, Radiation Research Society |
| 2015 - 2018 | GSBS Travel Award, MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences |
| 2014 | Med Into Grad Fellowship, Howard Hughes Medical Institute |
| 2013 | Highest Honours, Carleton University |
| 2011 | E.W.R. Steacie Scholarship, Carleton University |
| 2011 | I-CUREUS award, Carleton University |
| 2010 | Lester B. Pearson Scholarship, Carleton University |
| 2010 | E. Alison Flood Award in Physical Chemistry, Carleton Universty |
| 2009 - 2012 | Deans' Honour List, Carleton University |
| 2009 | Harry S. Southam Scholarship, Carleton University |
| 2008 | President's Scholarship, Carleton University |
Professional Memberships
Selected Presentations & Talks
National Presentations
- 2025. Empirical Proton RBE Modeling. Invited. Washington, DC, US.
- 2023. An Empirical Model to Predict Carbon Ion Relative Biological Effectiveness Based on the Linear Correlation between Radiosensitivity to Ions Versus x-Rays. Poster. Houston, TX, US.
- 2023. Relative Biological Effectiveness of an x-Ray Lens Converging Beam Radiotherapy System. Poster. Houston, TX, US.
- 2022. Comparison of Variable Proton RBE Model Predictions in the Treatment Plans of Patients Who Developed Radiation-Induced Necrosis. Conference. Washington, DC, US.
- 2022. Biological Optimization of Proton Radiotherapy Through Glutaminase 1 Inhibition. Conference. Washington, DC, US.
- 2022. Biological Optimization of Proton Radiotherapy through Glutaminase 1 Inhibition. Conference. Miami, FL, US.
- 2021. DNA Repair Inhibitors Combined with Protons Increase Cell Radiosensitivity in Vitro. Conference. Virtual, US.
- 2021. The Relative Variability in Radiosensitivity Between Cell Lines Is the Same for Carbon Ions, Protons and X-Rays. Conference. Virtual, US.
- 2020. A Phenomenological Model to Predict Carbon Ion Radiosensitivity and RBE On the Basis of a Cell Line's Photon Radiosensitivity. Conference. Virtual, US.
- 2019. The Non-Homologous End Joining Repair Pathway Determines Cell Radiosensitivity in Helium and Carbon Ion Beams. Conference. San Antonio, TX, US.
- 2018. The importance of DNA double strand break repair defects to cell radiosensitivity in helium and carbon ion beams. Conference. Nashville, TN, US.
- 2016. Sensitization of gold nanoshell-treated HT1080 fibrosarcoma cells exposed to 125 kVp x-rays. Poster. Waikoloa Village, HI, US.
- 2015. A Monte Carlo Investigation of Radiation Interactions with Gold Nanoparticles in Water for 6 MV, 85 KeV and 40 KeV Photon Beams. Poster. Anaheim, CA, US.
- 2012. The role of different luminescence centers on the dose response of Al2O3:C OSLDs: a systematic investigation using continuous wave and pulsed OSL readouts. Poster. Charlotte, NC, US.
International Presentations
- 2024. RBE Modeling in Ion Therapy. Invited. Global Medical Physics Education Series, US.
- 2017. The role of DNA double strand break repair deficiency on the sensitivity of cells to therapeutic proton beams. Poster. Radiation Research Society Annual Meeting. Cancun, MX.
- 2017. The role of DNA double strand break repair pathways in gold nanoparticle radiosensitizationin 6 MV x-ray beams. Poster. Radiation Research Society Annual Meeting. Cancun, MX.
Formal Peers
- 2022. Accounting for the variability in intrinsic radiosensitivity to protons. Houston, Texas, US.
Grant & Contract Support
| Date: | 2026 - 2028 |
| Title: | Towards an image-feature-based model of proton relative biological effectiveness |
| Funding Source: | NIH |
| Role: | Co-I |
| Date: | 2026 - 2028 |
| Title: | Towards an image-feature-based model of proton relative biological effectiveness |
| Funding Source: | Internal |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- Chiu HS, Somvanshi S, Chang CT, de Bony de Lavergne EJ, Wei Z, Hsieh CH, Trypsteen W, Scorsone KA, Patel E, Tang TT, Flint DB, Najaf Panah MJ, Kim HR, Rathi P, Lee YHW, Woodfield SE, Vasudevan SA, Heczey AA, Gaber MW, Sawakuchi GO, Sumazin P. Coordinated regulation by lncRNAs results in tight lncRNA-target couplings. Cell Genomics 5(8), 2025. e-Pub 2025. PMID: 40628267.
- Su T, Yu X, Hoseini-Ghahfarokhi M, Flint DB, Bright SJ, Antunes JIDS, Martinus DKJ, Manandhar M, Ben Kacem M, Marinello PC, Pereira EJG, Chiu HS, Titt U, Grosshans DR, Schuemann J, Willers H, Paganetti H, Sumazin P, Sawakuchi GO. Differentiation Stage Predicts Radiosensitivity in Mesenchymal-Like Pancreatic Cancer. Int J Radiat Oncol Biol Phys 123(1):270-281, 2025. e-Pub 2025. PMID: 40180058.
- Flint DB, Bright SJ, McFadden CH, Konishi T, Martinus DK, Manandhar M, Ben Kacem M, Bronk LF, Sawakuchi GO. An empirical model of carbon-ion relative biological effectiveness based on the linear correlation between radiosensitivity to photons and carbon ions. Physics in medicine and biology 69(24), 2024. e-Pub 2024. PMID: 39530708.
- Ben Kacem,M, Bright SJ, Moran E, Flint DB, Martinus DK, Turner B, Qureshi I, Kolachina RV, Manandhar M, Marinello P, Shaitelman SF, Sawakuchi GO. PARP inhibition radiosensitizes BRCA1 wildtype and mutated breast cancer to proton therapy. Scientific reports 14(1), 2024. e-Pub 2024. PMID: 39730675.
- Bright SJ, Manandhar M, Flint DB, Kolachina RV, Kacem MB, Martinus DK, Turner B, Qureshi I, McFadden CH, Marinello P, Shaitelman SF, Sawakuchi GO. ATR inhibition radiosensitizes cells through augmented DNA damage and G2 cell cycle arrest abrogation. JCI Insight 9(19), 2024. e-Pub 2024. PMID: 39235982.
- Flint DB, Ruff CE, Bright SJ, Yepes P, Wang Q, Manandhar M, Kacem MB, Turner BX, Martinus DK, Shaitelman SF, Sawakuchi GO. An empirical model of proton RBE based on the linear correlation between x‐ray and proton radiosensitivity. Med. Phys 49(9):6221-6236, 2022. e-Pub 2022.
- Bright SJ, Flint DB, Martinus DK, Turner BX, Manandhar M, Kacem MB, McFadden CH, Yap TA, Shaitelman SF, Sawakuchi GO. Targeted Inhibition of DNA-PKcs, ATM, ATR, PARP, and Rad51 Modulate Response to X Rays and Protons. Radiat. Res 198(4):336-346, 2022. e-Pub 2022.
- Manandhar M, Bright SJ, Flint DB, Martinus DK, Kolachina RV, Kacem MB, Titt U, Martin TJ, Lee CL, Morrison K, Shaitelman SF, Sawakuchi GO. Effect of boron compounds on the biological effectiveness of proton therapy. Med. Phys 49(9):6098-6109, 2022. e-Pub 2022.
- Bronk JK, Amer A, Khose S, Flint D, Adair A, Yepes P, Grosshans D, Johnson J, Chung C. Brain Radiation Necrosis Outside the Target Volume After Proton Radiation Therapy: Analyses of Multiparametric Imaging and Proton Biologic Effectiveness. Adv. Radiat. Oncol 7(6):101044, 2022. e-Pub 2022.
- Flint DB, Bright SJ, McFadden CH, Konishi T, Ohsawa D, Turner B, Lin SH, Grosshans, D.R., Chiu H-S, Sumazin P, Shaitelman SF, Sawakuchi GO. Cell lines of the same anatomic site and histologic type show large variability in intrinsic radiosensitivity and relative biological effectiveness to protons and carbon ions. Med. Phys 48:3243-3261, 2021. e-Pub 2021.
- McFadden CH, Rahmanian S, Flint DB, Bright SJ, Yoon DS, O'Brien DJ, Asaithamby A, Abdollahi A, Greilich S, Sawakuchi GO. Isolation of time-dependent DNA damage induced by energetic carbon ions and their fragments using fluorescent nuclear track detectors. Med. Phys 47:272-281, 2020. e-Pub 2020.
- Bright SJ, Flint DB, Chakraborty S, McFadden CH, Yoon DS, Bronk L, Titt U, Mohan R, Grosshans DR, Sumazin P, Shaitelman SF, Sawakuchi GO. Nonhomologous end joining is more important than proton linear energy transfer in dictating cell death. Int. J. Radiat. Oncol. Biol. Phys 105(5):1119-1125, 2019. e-Pub 2019.
- Flint DB, Granville DA, Sahoo N, McEwen M, Sawakuchi GO. Ionization density dependence of the curve shape and ratio of blue to UV emissions of Al2O3: C optically stimulated luminescence detectors exposed to 6-MV photon and therapeutic proton beams. Radiat. Meas 89:35-43, 2016. e-Pub 2016.
- McFadden CH, Hallacy TM, Flint DB, Granville DA, Asaithamby A, Sahoo N, Akselrod MS, Sawakuchi GO. Time-lapse monitoring of DNA damage colocalized with particle tracks in single living cells. Int. J. Radiat. Oncol. Biol. Phys 96(1):221-227, 2015. e-Pub 2015.
Abstracts
- FHoseini-Ghahfarokhi M,, Antunes J,, Su T,, Bright SJ,, Flint DB,, Manandhar M,, Marinello P,, Sawakuchi GO.. Testing the performance of RBE models using a comprehensive panel of pancreatic cancer cell lines. Med Phys, 2025. e-Pub 2025.
- Insley BA, Bocian B, Reiazi R, Jensen PJ Jr, Paulpeter RM, Niedzielski JS, Beddar S, Flint DB, Sawakuchi GO, Perles LA. Monte Carlo simulation of dose perturbations in HAM applicator HDR brachytherapy treatments. Med Phys, 2025. e-Pub 2025.
- Chaphuka C, Kumwembe M, Branco D, Flint DB, Bryant JM, Campbell J, Afanador R,, Mollura DJ,, Einstein SA,, Kemp JR,, Weygand J.. Establishing radiotherapy in Malawi through an international medical physics collaboration. Med Phys, 2025. e-Pub 2025.
- Flint D, Bright SJ, Sawakuchi GO, Grosshans D, Brock KK, Gaber MW, Tang TT. Predicting and Overcoming Radioresistance in the Treatment of Recurrent Medulloblastoma: A Preclinical Study 51(9):7005-7006, 2024. e-Pub 2024.
- Bright SJ,, Kolachina R, Manandhar M,, Ben Kacem M,, Marinello P, Flint DB,, Shaitelman S,, Sawakuchi GO.. A small molecule inhibitor targeting glutaminase-1 radiosensitizes lung cancer cell lines through metabolic disruption. Med Phys, 2024. e-Pub 2024.
- Manandhar M,, Bright SJ,, Marinello P, Flint DB, Ben Kacem M,, Martinus D, Su T,, Majithiya J, Piscitello D,, Shaitelman S,, Sawakuchi GO.. Radiosensitization to protons and photons by a novel ATR inhibitor in cancer cells. Med Phys, 2024. e-Pub 2024.
- Flint D, Bright S, Martinus D, Turner B, Manandhar M, Ben Kacem M, Shaitelman S, Sawakuchi G. An empirical model of proton RBE based on the linear correlation between proton and photon radiosensitivity 9(3):59, 2023. e-Pub 2023.
- Bright SJ,, Kolachina R,, Manandhar M,, Ben Kacem M,, Martinus D,, Marinello P,, Flint DB, Su T, Shaitelman S,, Sawakuchi GO. Biological optimization of proton radiotherapy through glutaminase 1 inhibition. Med Phys, 2023. e-Pub 2023.
- Ben Kacem M, Bright SJ,, Moran E,, Flint DB,, Martinus D, Manandhar M,, Marinello P,, Shaitelman S,, Sawakuchi GO. PARP inhibition increases the radiosensitization of breast cancer cells after radiation with photons and protons. Med Phys, 2023. e-Pub 2023.
- Marinello P, Manandhar M,, Bright SJ,, Martinus D, Ben Kacem M, Su T,, Flint DB,, Majithiya J,, Piscitello D,, Ranzani M,, Shaitelman S,, Sawakuchi GO. DNA polymerase theta inhibition selectively radiosensitizes tumors to photon and proton therapy regardless of homologous-recombination deficiency status. Med Phys, 2023. e-Pub 2023.
- Ben Kacem M, Moran E,, Flint DB,, Martinus D, Turner BX,, Bright SJ, Manandhar M, Marinello PC,, Su T,, Shaitelman SF, Sawakuchi GO. PARP inhibition combined with proton radiation enhances cell kill and senescence leading to immune signaling. Int J Part Ther, 2023. e-Pub 2023.
- Bright S,, Kolachina R,, Flint D, Martinus D,, Manandhar M,, Ben Kacem M, Marinello PC, Su T,, Shaitelman SF, Sawakuchi GO. Inhibition of glutaminase-1 (GLS1) increases the relative biological effectiveness of proton radiotherapy and increases levels of lipid peroxidation. Int J Part Ther, 2023. e-Pub 2023.
- Manandhar M,, Bright SJ,, Marinello P, Flint DB, Ben Kacem M,, Martinus D, Su T, Majithiya J,, Piscitello D,, Ranzani M, Shaitelman S, Sawakuchi GO. Radiosensitization of cancer cells to photon and proton radiation by the ATR inhibitor. Med Phys, 2023. e-Pub 2023.
- Manandhar M, Bright S, Flint D, Martinus D,, Kolachina R,, Ben Kacem M,, Lee C,, Morrison K,, Shaitelman S, Sawakuchi GO. Assessment of boron compounds on the biological effectiveness of proton therapy. Int J Part Ther, 2023. e-Pub 2023.
- Ben Kacem M,, Bright SJ,, Turner BX, Flint DB,, Manandhar M, McFadden CH,, Shaitelman SF,, Sawakuchi GO. PARP inhibition combined with protons enhances cell kill and might potentiate anti-tumor immune signaling. Int J Part Ther, 2023. e-Pub 2023.
- Tang T, Flint D, Bright S,, Grosshans D,, Gaber MW.. Proton therapy could offer a biologic advantage in the treatment of recurrent medulloblastoma. Int J Part Ther, 2023. e-Pub 2023.
- Manandhar M,, Bright SJ, Turner BX,, Flint DB, Ben Kacem M, Shaitelman SF, Sawakuchi GO. ATR inhibition disrupts DNA damage and cell cycle response to proton and photon radiation. Int J Part Ther, 2023. e-Pub 2023.
- Turner B, Bright S, Flint D, McFadden C,, Sawakuchi GO, Shaitelman S.. Protons combined with an inhibitor of ATR amplify micronuclei and potentiate anti-tumor immune signaling. Int J Part Ther, 2023. e-Pub 2023.
- Bright S,, Flint D,, Turner B,, Manandhar M,, McFadden C, Martinus D,, Ben Kacem M, Shaitelman S, Sawakuchi GO. DNA repair inhibitors modulate cancer cell survival to photons and protons. Int J Part Ther, 2023. e-Pub 2023.
- Flint DB, Bright SF, Martinus D, Manandhar M, Ben Kacem M, Shaitelman S, Sawakuchi GO. An Empirical Model to Predict Carbon Ion Relative Biological Effectiveness Based on the Linear Correlation between Radiosensitivity to Ions Versus x-Rays 50(6):e262, 2023. e-Pub 2023.
- Flint DB, Barkoski DA, Akhavan S, Che Fru L, Salehpour MR, Sawakuchi GO. Relative Biological Effectiveness of an x-Ray Lens Converging Beam Radiotherapy System 50(6):e318, 2023. e-Pub 2023.
- Flint D, Zhang T, Yepes P, Adair A, Wang Q, Ruff C, Engeseth G, Gunn B, Shaitelman S, Sawakuchi G. Comparison of Variable Proton RBE Model Predictions in the Treatment Plans of Patients Who Developed Radiation-Induced Necrosis 49(6):e597, 2022. e-Pub 2022.
- Moran E, Ben Kacem M, Flint D, Martinus D,, Bright S,, Manandhar M,, Shaitelman S,, Sawakuchi GO. Investigating immune response induced in breast cancer cells across varying radiation type, PARPi concentration, and BRCA status. Med Phys, 2022. e-Pub 2022.
- Martinus D, Flint D, Bright S,, Titt U,, Shaitelman S, Sawakuchi GO. Estimation of uncertainties in the distal edge of proton beams introduced by inherent variations in the thickness of plates used to perform radiobiology experiments. Med Phys, 2022. e-Pub 2022.
- Martinus D,, Flint D, Bright S,, Khuroo M,, Prajapati S, Shaitelman S,, Sawakuchi GO. High throughput alpha particle irradiator for radiobiology research. Med Phys, 2022. e-Pub 2022.
- Flint D, Bright S, Kolachina R, Martinus D, Manandhar M, Ben Kacem M, Marinello P, Su T, Shaitelman S, Sawakuchi G. Biological Optimization of Proton Radiotherapy Through Glutaminase 1 Inhibition 49(6):e597, 2022. e-Pub 2022.
- Ben Kacem M, Bright S, Turner B, Flint D,, Manandhar M,, Martinus D,, McFadden C,, Shaitelman S,, Sawakuchi GO. Protons combined with PARP inhibition sensitize cancer cells and activate immune signaling more than photons. Med Phys, 2021. e-Pub 2021.
- Flint D, Bright S, Turner B, Manandhar M, Ben Kacem M, Martinus D, Shaitelman S, Sawakuchi G. The Relative Variability in Radiosensitivity Between Cell Lines Is the Same for Carbon Ions, Protons and X-Rays 48(6):2021, 2021. e-Pub 2021.
- Flint D, Bright S, Turner B, Manandhar M, Ben Kacem M, Shaitelman S, Sawakuchi G. DNA Repair Inhibitors Combined with Protons Increase Cell Radiosensitivity in Vitro 48(6):e147, 2021. e-Pub 2021.
- Bright S,, Turner B,, Manandhar M,, McFadden C,, Flint D, Martinus D, Ben Kacem M, Shaitelman S, Sawakuchi GO. A DNA repair inhibitor targeting ATR modulates immune responses to radiotherapy. Med Phys, 2021. e-Pub 2021.
- Manandhar M, Bright S, Turner B, Flint D,, Ben Kacem M,, Martinus D,, Shaitelman S, Sawakuchi GO. Hypersensitivity of cancer cells to photon and proton radiation caused by disruption of cell cycle arrest by an ATR inhibitor. Med Phys, 2021. e-Pub 2021.
- Turner B, Bright S,, Flint D, Sawakuchi GO, Shaitelman S,, Manandhar M, Ben Kacem M,, Martinus D. The combined effects of protons and an inhibitor of ATR increase micronuclei formation and potentiate anti-tumor immunity. Med Phys, 2021. e-Pub 2021.
- Martinus D, Bright S,, Flint D, Turner B,, Manandhar M, Ben Kacem M,, Shaitelman S,, Sawakuchi GO. ATR inhibition suppresses DNA damage signaling and sensitizes cancer cells to photons and protons. Med Phys, 2021. e-Pub 2021.
- Flint D, Bright S, McFadden C, Konishi T, Ohsawa D, Kobayashi A, Shaitelman S, Sawakuchi G. A Phenomenological Model to Predict Carbon Ion Radiosensitivity and RBE On the Basis of a Cell Line's Photon Radiosensitivity 47(6):e353, 2020. e-Pub 2020.
- Flint D, Bright S, McFadden C, Chakraborty S, Yoon D, Shaitelman S, Kodaira S, Konishi T, Sawakuchi G. BEST IN PHYSICS (THERAPY): The Non-Homologous End Joining Repair Pathway Determines Cell Radiosensitivity in Helium and Carbon Ion Beams 46(6):e456, 2019. e-Pub 2019.
- Bright S, Flint D, McFadden C, Yoon D,, Aroumougame A,, Sawakuchi GO. Role of DNA double strand break repair deficiency on the sensitivity of cells to therapeutic proton beams. Med Phys, 2018. e-Pub 2018.
- McFadden C,, Rahmanian C,, Flint D, Bright S, O'Brien D, Aroumougame A,, Abdollahi A, Greilich S, Sawakuchi GO. Linking single-site DNA damage response to individual charged particle type in C-ion radiotherapy beams. Med Phys, 2018. e-Pub 2018.
- Flint D, McFadden C, Bright S, Yoon D, Kodaira S, Konishi T, Sawakuchi G. The importance of DNA double strand break repair defects to cell radiosensitivity in helium and carbon ion beams 45:2769, 2018. e-Pub 2018.
- McFadden C,, Flint D,, Sadetaporn D,, Asaithamby A, Grosshans D, Sawakuchi GO. A portable confocal microscope to image live cell damage response induced by therapeutic radiation. Med Phys, 2016. e-Pub 2016.
- Sadetaporn D, Flint D, McFadden C,, Asaithamby A, Grosshans D,, Sawakuchi GO. Confocal microscopy imaging of cell cycle distribution in cells treated with pegylated gold nanoshells. Med Phys, 2016. e-Pub 2016.
- Flint DB, O'Brien DJ, McFadden CH, Hallacy TM, Wolfe T, Krishnan S, Sawakuchi GO. A Monte Carlo Investigation of Radiation Interactions with Gold Nanoparticles in Water for 6 MV, 85 KeV and 40 KeV Photon Beams 42:3341, 2015. e-Pub 2015.
- Granville DA,, Flint DB, Sawakuchi GO.. OSL response of Al₂O₃:C detectors exposed to therapeutic proton beams. Med Phys, 2015. e-Pub 2015.
- Mathis M,, Wen Z,, Tailor R, Sawakuchi GO, Flint DB, Beddar S,, Ibbott GS. Effect of a strong magnetic field on select radiation dosimeters. Med Phys, 2014. e-Pub 2014.
- Flint D, Granville D, Sawakuchi G. The role of different luminescence centers on the dose response of Al2O3:C OSLDs: a systematic investigation using continuous wave and pulsed OSL readouts 39:3717, 2012. e-Pub 2012.
Patient Reviews
CV information above last modified July 22, 2026